Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF7
|
ENSG00000118263.10 | Kruppel like factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_208006684_208006835 | KLF7 | 7898 | 0.200545 | -0.88 | 1.9e-03 | Click! |
chr2_208000784_208000935 | KLF7 | 1998 | 0.329023 | -0.78 | 1.3e-02 | Click! |
chr2_208000481_208000742 | KLF7 | 1750 | 0.362101 | -0.73 | 2.5e-02 | Click! |
chr2_208017651_208017818 | KLF7 | 12561 | 0.197360 | -0.69 | 4.1e-02 | Click! |
chr2_208029828_208030644 | KLF7 | 59 | 0.978988 | 0.68 | 4.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_111415846_111416285 | 0.99 |
CD53 |
CD53 molecule |
289 |
0.91 |
chrX_129218649_129218800 | 0.98 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
25612 |
0.18 |
chr18_43268798_43268949 | 0.95 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
22766 |
0.16 |
chr2_151412976_151413127 | 0.84 |
RND3 |
Rho family GTPase 3 |
17526 |
0.31 |
chr6_47666951_47667231 | 0.82 |
GPR115 |
G protein-coupled receptor 115 |
802 |
0.64 |
chr8_1431231_1431382 | 0.77 |
DLGAP2 |
discs, large (Drosophila) homolog-associated protein 2 |
18226 |
0.28 |
chr17_7210033_7210519 | 0.75 |
EIF5A |
eukaryotic translation initiation factor 5A |
42 |
0.92 |
chr19_55765720_55766271 | 0.73 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
1142 |
0.27 |
chr11_20178638_20179031 | 0.73 |
DBX1 |
developing brain homeobox 1 |
3036 |
0.31 |
chr11_73490222_73490495 | 0.73 |
MRPL48 |
mitochondrial ribosomal protein L48 |
8003 |
0.15 |
chr2_110970201_110970394 | 0.73 |
NPHP1 |
nephronophthisis 1 (juvenile) |
7654 |
0.23 |
chr6_116600126_116600342 | 0.70 |
TSPYL1 |
TSPY-like 1 |
832 |
0.44 |
chr3_47050667_47050875 | 0.69 |
NBEAL2 |
neurobeachin-like 2 |
4000 |
0.22 |
chr14_105331028_105331307 | 0.69 |
CEP170B |
centrosomal protein 170B |
450 |
0.81 |
chr1_9713633_9713784 | 0.67 |
C1orf200 |
chromosome 1 open reading frame 200 |
936 |
0.49 |
chr15_66649119_66649300 | 0.66 |
TIPIN |
TIMELESS interacting protein |
155 |
0.92 |
chr2_74165845_74165996 | 0.65 |
DGUOK |
deoxyguanosine kinase |
11885 |
0.15 |
chr19_48111330_48111585 | 0.65 |
GLTSCR1 |
glioma tumor suppressor candidate region gene 1 |
4 |
0.97 |
chr12_113770815_113771205 | 0.65 |
SLC8B1 |
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
258 |
0.91 |
chr17_37558067_37558428 | 0.64 |
CTB-131K11.1 |
|
201 |
0.65 |
chrX_92928498_92928999 | 0.63 |
NAP1L3 |
nucleosome assembly protein 1-like 3 |
181 |
0.61 |
chr14_50985374_50985525 | 0.63 |
MAP4K5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
13741 |
0.17 |
chr5_156968041_156968238 | 0.62 |
AC106801.1 |
|
24833 |
0.14 |
chr3_33138761_33138999 | 0.62 |
GLB1 |
galactosidase, beta 1 |
158 |
0.84 |
chr6_45983691_45983842 | 0.62 |
CLIC5 |
chloride intracellular channel 5 |
180 |
0.95 |
chr4_83350861_83351264 | 0.61 |
HNRNPDL |
heterogeneous nuclear ribonucleoprotein D-like |
43 |
0.93 |
chr1_89989972_89990271 | 0.61 |
LRRC8B |
leucine rich repeat containing 8 family, member B |
274 |
0.94 |
chr2_16081463_16081614 | 0.60 |
MYCNOS |
MYCN opposite strand |
166 |
0.89 |
chr13_74339708_74339938 | 0.60 |
KLF12 |
Kruppel-like factor 12 |
229363 |
0.02 |
chr6_36164322_36164500 | 0.58 |
BRPF3 |
bromodomain and PHD finger containing, 3 |
110 |
0.88 |
chr9_132653009_132653160 | 0.58 |
FNBP1 |
formin binding protein 1 |
28505 |
0.14 |
chr8_79577906_79578162 | 0.57 |
ZC2HC1A |
zinc finger, C2HC-type containing 1A |
248 |
0.95 |
chr2_201577972_201578363 | 0.57 |
AOX1 |
aldehyde oxidase 1 |
50537 |
0.11 |
chr7_157072586_157072755 | 0.57 |
ENSG00000266453 |
. |
25817 |
0.21 |
chr13_76334632_76334929 | 0.57 |
LMO7 |
LIM domain 7 |
15 |
0.99 |
chr6_25042448_25042685 | 0.56 |
FAM65B |
family with sequence similarity 65, member B |
328 |
0.63 |
chr1_26872331_26872899 | 0.56 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
272 |
0.88 |
chr10_105880540_105880741 | 0.56 |
SFR1 |
SWI5-dependent recombination repair 1 |
1176 |
0.46 |
chr16_69516663_69516814 | 0.56 |
CYB5B |
cytochrome b5 type B (outer mitochondrial membrane) |
58052 |
0.09 |
chr1_154315658_154315860 | 0.55 |
ENSG00000238365 |
. |
4540 |
0.12 |
chr3_197476356_197476565 | 0.55 |
FYTTD1 |
forty-two-three domain containing 1 |
36 |
0.58 |
chr9_95727201_95727619 | 0.55 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1167 |
0.54 |
chr16_22384493_22384879 | 0.55 |
CDR2 |
cerebellar degeneration-related protein 2, 62kDa |
1252 |
0.31 |
chr11_112833488_112833639 | 0.54 |
RP11-629G13.1 |
|
619 |
0.65 |
chr11_65029483_65029818 | 0.54 |
POLA2 |
polymerase (DNA directed), alpha 2, accessory subunit |
217 |
0.91 |
chr7_104584495_104584838 | 0.54 |
ENSG00000251911 |
. |
27068 |
0.16 |
chr14_75990098_75990249 | 0.53 |
BATF |
basic leucine zipper transcription factor, ATF-like |
1270 |
0.47 |
chr12_62656333_62656484 | 0.53 |
USP15 |
ubiquitin specific peptidase 15 |
2199 |
0.3 |
chr17_33673306_33673493 | 0.53 |
SLFN11 |
schlafen family member 11 |
6751 |
0.2 |
chr12_53773389_53773606 | 0.52 |
SP1 |
Sp1 transcription factor |
463 |
0.73 |
chr1_109757024_109757692 | 0.52 |
SARS |
seryl-tRNA synthetase |
754 |
0.58 |
chr3_57677289_57677722 | 0.52 |
DENND6A |
DENN/MADD domain containing 6A |
1311 |
0.4 |
chr21_42741228_42741619 | 0.51 |
MX2 |
myxovirus (influenza virus) resistance 2 (mouse) |
589 |
0.77 |
chr9_73026582_73027022 | 0.51 |
KLF9 |
Kruppel-like factor 9 |
2738 |
0.37 |
chr2_96657272_96657655 | 0.51 |
ANKRD36C |
ankyrin repeat domain 36C |
78 |
0.97 |
chr12_113494960_113495179 | 0.51 |
DTX1 |
deltex homolog 1 (Drosophila) |
426 |
0.82 |
chr2_85153190_85153512 | 0.51 |
TMSB10 |
thymosin beta 10 |
20602 |
0.17 |
chr3_111260963_111261300 | 0.51 |
CD96 |
CD96 molecule |
134 |
0.97 |
chr8_8203302_8203453 | 0.51 |
SGK223 |
Tyrosine-protein kinase SgK223 |
35880 |
0.18 |
chr12_133083604_133083856 | 0.50 |
FBRSL1 |
fibrosin-like 1 |
16573 |
0.19 |
chr3_9690857_9691008 | 0.50 |
MTMR14 |
myotubularin related protein 14 |
185 |
0.94 |
chr16_86638626_86639076 | 0.49 |
FOXL1 |
forkhead box L1 |
26736 |
0.16 |
chr11_73692681_73692970 | 0.49 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
842 |
0.53 |
chr10_134716551_134716702 | 0.49 |
TTC40 |
tetratricopeptide repeat domain 40 |
39463 |
0.18 |
chr6_89790098_89790249 | 0.49 |
RP11-63L7.5 |
|
213 |
0.59 |
chr6_36973743_36974036 | 0.49 |
FGD2 |
FYVE, RhoGEF and PH domain containing 2 |
466 |
0.8 |
chr2_46524572_46524838 | 0.49 |
EPAS1 |
endothelial PAS domain protein 1 |
164 |
0.97 |
chr1_249131820_249131984 | 0.49 |
ZNF672 |
zinc finger protein 672 |
577 |
0.67 |
chr4_185182739_185182890 | 0.48 |
ENSG00000221523 |
. |
5770 |
0.22 |
chr5_67510861_67511301 | 0.48 |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
467 |
0.86 |
chr2_207115371_207115541 | 0.48 |
ENSG00000252716 |
. |
9482 |
0.15 |
chr8_133787726_133787926 | 0.47 |
PHF20L1 |
PHD finger protein 20-like 1 |
0 |
0.98 |
chr13_101169809_101169960 | 0.47 |
PCCA |
propionyl CoA carboxylase, alpha polypeptide |
2203 |
0.29 |
chr14_103010712_103010863 | 0.47 |
ENSG00000266015 |
. |
4806 |
0.19 |
chr5_159846201_159846839 | 0.47 |
SLU7 |
SLU7 splicing factor homolog (S. cerevisiae) |
119 |
0.95 |
chr15_65282464_65282690 | 0.47 |
SPG21 |
spastic paraplegia 21 (autosomal recessive, Mast syndrome) |
71 |
0.97 |
chr6_4136387_4136965 | 0.47 |
ECI2 |
enoyl-CoA delta isomerase 2 |
845 |
0.44 |
chr9_139433085_139433378 | 0.46 |
RP11-413M3.4 |
|
4102 |
0.11 |
chr12_14518654_14518864 | 0.46 |
ATF7IP |
activating transcription factor 7 interacting protein |
96 |
0.98 |
chr9_33001711_33002097 | 0.46 |
APTX |
aprataxin |
265 |
0.91 |
chr3_150479775_150480371 | 0.46 |
SIAH2-AS1 |
SIAH2 antisense RNA 1 |
349 |
0.79 |
chr15_81426280_81426524 | 0.46 |
C15orf26 |
chromosome 15 open reading frame 26 |
186 |
0.96 |
chr5_36876188_36876410 | 0.46 |
NIPBL |
Nipped-B homolog (Drosophila) |
562 |
0.86 |
chr10_8068775_8069028 | 0.46 |
GATA3 |
GATA binding protein 3 |
27755 |
0.26 |
chr11_62308687_62309106 | 0.46 |
RP11-864I4.3 |
|
4112 |
0.1 |
chr11_62647941_62648236 | 0.45 |
SLC3A2 |
solute carrier family 3 (amino acid transporter heavy chain), member 2 |
194 |
0.87 |
chr22_38793180_38793744 | 0.45 |
CSNK1E |
casein kinase 1, epsilon |
1065 |
0.4 |
chr18_33530285_33530492 | 0.45 |
ENSG00000265641 |
. |
16283 |
0.17 |
chr5_90576543_90576733 | 0.44 |
ENSG00000199643 |
. |
10094 |
0.28 |
chr2_74710229_74710420 | 0.44 |
CCDC142 |
coiled-coil domain containing 142 |
37 |
0.56 |
chr9_130733348_130733499 | 0.44 |
FAM102A |
family with sequence similarity 102, member A |
9369 |
0.11 |
chr19_15580698_15580960 | 0.43 |
RASAL3 |
RAS protein activator like 3 |
5447 |
0.13 |
chr12_52463075_52463333 | 0.43 |
C12orf44 |
chromosome 12 open reading frame 44 |
551 |
0.63 |
chr6_33239851_33240264 | 0.43 |
RPS18 |
ribosomal protein S18 |
205 |
0.61 |
chr22_31031104_31031465 | 0.43 |
SLC35E4 |
solute carrier family 35, member E4 |
355 |
0.81 |
chr2_70314282_70314484 | 0.43 |
PCBP1-AS1 |
PCBP1 antisense RNA 1 |
53 |
0.7 |
chr12_31226828_31227064 | 0.43 |
DDX11 |
DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 |
114 |
0.57 |
chr12_120428180_120428604 | 0.43 |
CCDC64 |
coiled-coil domain containing 64 |
719 |
0.72 |
chr19_6590606_6591184 | 0.43 |
CD70 |
CD70 molecule |
255 |
0.89 |
chr17_3289151_3289302 | 0.43 |
RP11-64J4.2 |
|
361 |
0.82 |
chr4_2801611_2801762 | 0.43 |
SH3BP2 |
SH3-domain binding protein 2 |
961 |
0.59 |
chr1_26646074_26646278 | 0.42 |
UBXN11 |
UBX domain protein 11 |
1322 |
0.27 |
chr17_76109268_76109419 | 0.42 |
ENSG00000204282 |
. |
1463 |
0.29 |
chr7_27200041_27200697 | 0.42 |
HOXA7 |
homeobox A7 |
2814 |
0.08 |
chr16_79630640_79632238 | 0.42 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
2360 |
0.43 |
chr6_35267446_35267597 | 0.41 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1892 |
0.32 |
chr6_33539685_33539836 | 0.41 |
BAK1 |
BCL2-antagonist/killer 1 |
8221 |
0.13 |
chr3_32442741_32443149 | 0.41 |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
9414 |
0.25 |
chr11_726415_726634 | 0.41 |
AP006621.9 |
|
523 |
0.57 |
chr15_50004365_50004516 | 0.41 |
RP11-353B9.1 |
|
60104 |
0.12 |
chr13_22178024_22178253 | 0.41 |
MICU2 |
mitochondrial calcium uptake 2 |
182 |
0.96 |
chr19_17590091_17590333 | 0.40 |
SLC27A1 |
solute carrier family 27 (fatty acid transporter), member 1 |
8914 |
0.08 |
chr19_46172257_46172467 | 0.40 |
GIPR |
gastric inhibitory polypeptide receptor |
847 |
0.37 |
chr1_205819043_205819299 | 0.40 |
PM20D1 |
peptidase M20 domain containing 1 |
74 |
0.97 |
chr19_51522437_51522588 | 0.40 |
KLK10 |
kallikrein-related peptidase 10 |
508 |
0.54 |
chrX_45709671_45710004 | 0.40 |
ENSG00000212347 |
. |
42577 |
0.19 |
chr19_17622094_17622308 | 0.40 |
PGLS |
6-phosphogluconolactonase |
237 |
0.85 |
chr15_75199296_75199599 | 0.40 |
FAM219B |
family with sequence similarity 219, member B |
15 |
0.96 |
chr17_8089749_8090065 | 0.40 |
ENSG00000266638 |
. |
586 |
0.5 |
chr15_41047576_41047750 | 0.39 |
RMDN3 |
regulator of microtubule dynamics 3 |
129 |
0.93 |
chr10_102588726_102589022 | 0.39 |
ENSG00000222072 |
. |
78163 |
0.07 |
chr19_2775817_2776209 | 0.39 |
SGTA |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha |
5234 |
0.12 |
chr4_56719874_56720283 | 0.39 |
EXOC1 |
exocyst complex component 1 |
173 |
0.95 |
chr10_124135009_124135427 | 0.39 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
868 |
0.6 |
chr2_74881058_74881259 | 0.39 |
SEMA4F |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4F |
197 |
0.93 |
chr6_116597784_116598857 | 0.39 |
TSPYL1 |
TSPY-like 1 |
2746 |
0.21 |
chr10_111986414_111986565 | 0.39 |
MXI1 |
MAX interactor 1, dimerization protein |
647 |
0.75 |
chr10_12110997_12111197 | 0.39 |
DHTKD1 |
dehydrogenase E1 and transketolase domain containing 1 |
74 |
0.97 |
chr12_9436279_9436529 | 0.39 |
ENSG00000212440 |
. |
3014 |
0.25 |
chr11_117860694_117860845 | 0.38 |
IL10RA |
interleukin 10 receptor, alpha |
3660 |
0.23 |
chr1_49242712_49243015 | 0.38 |
BEND5 |
BEN domain containing 5 |
273 |
0.95 |
chr10_97667704_97667951 | 0.38 |
C10orf131 |
chromosome 10 open reading frame 131 |
105 |
0.62 |
chr11_72853974_72854211 | 0.38 |
FCHSD2 |
FCH and double SH3 domains 2 |
786 |
0.69 |
chr1_26231368_26231927 | 0.38 |
STMN1 |
stathmin 1 |
28 |
0.94 |
chr17_13241369_13241749 | 0.38 |
ENSG00000266115 |
. |
162086 |
0.04 |
chr1_173793809_173794356 | 0.38 |
DARS2 |
aspartyl-tRNA synthetase 2, mitochondrial |
285 |
0.7 |
chr1_154927193_154927621 | 0.38 |
PBXIP1 |
pre-B-cell leukemia homeobox interacting protein 1 |
1173 |
0.25 |
chr8_8746534_8747046 | 0.37 |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
4365 |
0.23 |
chr19_49403923_49404430 | 0.37 |
NUCB1 |
nucleobindin 1 |
121 |
0.9 |
chr14_100704060_100704316 | 0.37 |
YY1 |
YY1 transcription factor |
447 |
0.56 |
chr5_72251288_72251681 | 0.37 |
FCHO2 |
FCH domain only 2 |
324 |
0.92 |
chrX_154285608_154285801 | 0.37 |
CMC4 |
C-x(9)-C motif containing 4 |
7939 |
0.14 |
chr1_26561482_26561883 | 0.37 |
CEP85 |
centrosomal protein 85kDa |
989 |
0.41 |
chrX_80457617_80458353 | 0.37 |
SH3BGRL |
SH3 domain binding glutamic acid-rich protein like |
543 |
0.46 |
chr8_23075544_23076103 | 0.37 |
ENSG00000246582 |
. |
6161 |
0.12 |
chr17_33814121_33814953 | 0.36 |
SLFN12L |
schlafen family member 12-like |
316 |
0.84 |
chr7_150373814_150373965 | 0.36 |
GIMAP2 |
GTPase, IMAP family member 2 |
8899 |
0.17 |
chr3_56591241_56591766 | 0.36 |
CCDC66 |
coiled-coil domain containing 66 |
287 |
0.94 |
chr12_4381277_4381428 | 0.36 |
CCND2 |
cyclin D2 |
1586 |
0.32 |
chr10_43133374_43133621 | 0.36 |
ZNF33B |
zinc finger protein 33B |
495 |
0.85 |
chr9_130736775_130737070 | 0.36 |
FAM102A |
family with sequence similarity 102, member A |
5870 |
0.12 |
chr8_128806891_128807842 | 0.36 |
ENSG00000249859 |
. |
842 |
0.72 |
chr14_64107873_64108536 | 0.36 |
WDR89 |
WD repeat domain 89 |
79 |
0.96 |
chr6_144385545_144385940 | 0.36 |
PLAGL1 |
pleiomorphic adenoma gene-like 1 |
7 |
0.98 |
chr6_26597613_26597959 | 0.36 |
ABT1 |
activator of basal transcription 1 |
606 |
0.73 |
chr7_150070289_150070440 | 0.36 |
RP4-584D14.5 |
|
685 |
0.5 |
chrX_129245186_129245676 | 0.35 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
740 |
0.69 |
chr20_44486283_44486492 | 0.35 |
ZSWIM3 |
zinc finger, SWIM-type containing 3 |
131 |
0.72 |
chr5_99228364_99228515 | 0.35 |
ENSG00000199378 |
. |
129069 |
0.06 |
chr17_4709881_4710063 | 0.35 |
PLD2 |
phospholipase D2 |
419 |
0.67 |
chr4_24584331_24584482 | 0.35 |
DHX15 |
DEAH (Asp-Glu-Ala-His) box helicase 15 |
1767 |
0.4 |
chr5_74348140_74348479 | 0.35 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
21585 |
0.25 |
chr14_57046740_57047215 | 0.35 |
TMEM260 |
transmembrane protein 260 |
375 |
0.91 |
chr13_53226532_53226731 | 0.35 |
SUGT1 |
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae) |
343 |
0.9 |
chr14_21131236_21131389 | 0.35 |
ENSG00000199461 |
. |
16258 |
0.09 |
chr8_9008533_9008971 | 0.35 |
PPP1R3B |
protein phosphatase 1, regulatory subunit 3B |
332 |
0.62 |
chr1_147807090_147807347 | 0.35 |
ENSG00000202408 |
. |
332 |
0.85 |
chrX_149860911_149861411 | 0.35 |
MTMR1 |
myotubularin related protein 1 |
274 |
0.95 |
chr16_9184823_9185042 | 0.35 |
C16orf72 |
chromosome 16 open reading frame 72 |
573 |
0.72 |
chr6_137540064_137540505 | 0.34 |
IFNGR1 |
interferon gamma receptor 1 |
215 |
0.96 |
chr22_32366297_32366691 | 0.34 |
ENSG00000240647 |
. |
10920 |
0.14 |
chr16_11438920_11439177 | 0.34 |
RP11-485G7.5 |
|
6 |
0.75 |
chr22_38349726_38350087 | 0.34 |
POLR2F |
polymerase (RNA) II (DNA directed) polypeptide F |
172 |
0.56 |
chr17_46115604_46115869 | 0.34 |
COPZ2 |
coatomer protein complex, subunit zeta 2 |
344 |
0.7 |
chr17_72734396_72734547 | 0.34 |
RAB37 |
RAB37, member RAS oncogene family |
1100 |
0.33 |
chr12_104851638_104851843 | 0.34 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
961 |
0.68 |
chr19_46171751_46172236 | 0.34 |
GIPR |
gastric inhibitory polypeptide receptor |
478 |
0.61 |
chr4_109087549_109087740 | 0.34 |
LEF1 |
lymphoid enhancer-binding factor 1 |
187 |
0.91 |
chr20_31330734_31331002 | 0.34 |
COMMD7 |
COMM domain containing 7 |
344 |
0.88 |
chr9_276345_276496 | 0.34 |
DOCK8 |
dedicator of cytokinesis 8 |
3350 |
0.24 |
chr22_43411396_43411716 | 0.34 |
PACSIN2 |
protein kinase C and casein kinase substrate in neurons 2 |
405 |
0.85 |
chr20_32262337_32262536 | 0.34 |
RP1-63M2.5 |
|
113 |
0.56 |
chr17_45811310_45811575 | 0.34 |
TBX21 |
T-box 21 |
832 |
0.55 |
chr17_21454142_21454502 | 0.34 |
C17orf51 |
chromosome 17 open reading frame 51 |
621 |
0.75 |
chr5_54830989_54831249 | 0.34 |
PPAP2A |
phosphatidic acid phosphatase type 2A |
241 |
0.94 |
chr2_43037752_43038106 | 0.34 |
HAAO |
3-hydroxyanthranilate 3,4-dioxygenase |
18197 |
0.23 |
chr2_192176235_192176432 | 0.34 |
MYO1B |
myosin IB |
34722 |
0.2 |
chrX_130912849_130913434 | 0.34 |
ENSG00000200587 |
. |
159843 |
0.04 |
chr7_99647395_99647894 | 0.34 |
ZSCAN21 |
zinc finger and SCAN domain containing 21 |
227 |
0.84 |
chr20_5731235_5731458 | 0.33 |
C20orf196 |
chromosome 20 open reading frame 196 |
247 |
0.95 |
chr16_2317361_2317547 | 0.33 |
RNPS1 |
RNA binding protein S1, serine-rich domain |
116 |
0.77 |
chr16_72127792_72128009 | 0.33 |
DHX38 |
DEAH (Asp-Glu-Ala-His) box polypeptide 38 |
77 |
0.57 |
chr6_106546757_106547354 | 0.33 |
PRDM1 |
PR domain containing 1, with ZNF domain |
240 |
0.87 |
chr17_37025636_37026147 | 0.33 |
LASP1 |
LIM and SH3 protein 1 |
221 |
0.86 |
chr1_12128033_12128184 | 0.33 |
TNFRSF8 |
tumor necrosis factor receptor superfamily, member 8 |
4581 |
0.16 |
chr22_39640196_39640514 | 0.33 |
PDGFB |
platelet-derived growth factor beta polypeptide |
401 |
0.8 |
chr15_67547384_67547573 | 0.33 |
AAGAB |
alpha- and gamma-adaptin binding protein |
55 |
0.81 |
chr19_7694674_7695267 | 0.33 |
PET100 |
PET100 homolog (S. cerevisiae) |
260 |
0.65 |
chr20_61437961_61438112 | 0.33 |
OGFR |
opioid growth factor receptor |
589 |
0.53 |
chr19_45251774_45251925 | 0.33 |
BCL3 |
B-cell CLL/lymphoma 3 |
45 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.2 | 0.7 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.2 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.3 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.2 | GO:2000330 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.1 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.3 | GO:0031427 | response to methotrexate(GO:0031427) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.4 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.1 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.4 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.2 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.0 | 0.1 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.0 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.2 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.2 | GO:0043302 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.1 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.2 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.3 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.0 | 0.3 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.2 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.4 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.8 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.0 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.2 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.0 | 0.3 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.0 | 0.1 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.2 | GO:0072087 | renal vesicle development(GO:0072087) |
0.0 | 0.4 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.0 | 0.0 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.0 | 0.1 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.0 | 0.1 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.0 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.0 | 0.1 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.1 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.3 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.3 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.0 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.7 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.1 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.0 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0009158 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.1 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.2 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.0 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.0 | 0.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.0 | GO:0097300 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.0 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.0 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.2 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.0 | 0.2 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.2 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
0.0 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.0 | 0.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.2 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0043247 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.0 | 0.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.0 | 0.1 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.2 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.0 | 0.3 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.0 | GO:0031223 | auditory behavior(GO:0031223) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.4 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.0 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0046931 | pore complex assembly(GO:0046931) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 1.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 1.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.1 | GO:0031113 | regulation of microtubule polymerization(GO:0031113) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.0 | GO:0070234 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
0.0 | 0.2 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.0 | GO:0021783 | facial nerve development(GO:0021561) preganglionic parasympathetic fiber development(GO:0021783) |
0.0 | 0.2 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.0 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0052555 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) positive regulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052555) positive regulation by symbiont of host immune response(GO:0052556) |
0.0 | 0.1 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.1 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0045010 | actin nucleation(GO:0045010) |
0.0 | 0.3 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 1.3 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.2 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.0 | 0.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0051955 | regulation of amino acid transport(GO:0051955) |
0.0 | 0.1 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.5 | GO:0006826 | iron ion transport(GO:0006826) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.7 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 1.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.1 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.0 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
0.0 | 2.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 1.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0030894 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.9 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.7 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.9 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.5 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 1.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.5 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 2.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.0 | GO:0045277 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 2.9 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.0 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.6 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.4 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 0.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 0.6 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.3 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 1.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.0 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.6 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.0 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.3 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.0 | 0.0 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.5 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 2.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.3 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 1.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.0 | 0.0 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.5 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.0 | 0.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.0 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.0 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.0 | 0.3 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |